Behavioral Health Market Research Reports & Industry Analysis
Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders. Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behavior therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone.
The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.
Behavioral Health Industry Research & Market Reports
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Global Self-improvement Products & Services Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... way to challenge yourself in new ways while promoting personal growth. Self-improvement Products & Services can help improve people physically, mentally, financially or spiritually. Market Overview: The latest research study on the global Self-improvement Products ... Read More
-
Bipolar Disorder treatment Market, By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Bipolar disorder is a lifelong disease, which can be managed with proper medication. The medications used to manage bipolar disorder symptoms ... Read More
-
Psychedelic Drugs: Global Market Outlook
... competitive intelligence and regional trends. It also discusses market the competitive scenarios that will form the base data for qualitative analysis and market estimates. In this report, the global market for psychedelic drugs is segmented ... Read More
-
Global Mental Health Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Observational, Expanded Access) by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Government Agencies, Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029
... Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029 Global Mental Health Clinical Trials Market is valued at approximately USD XX billion in 2021 and ... Read More
-
Anxiety Disorders and Depression Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... The COVID-19 outbreak significantly impacted the growth due to the increased number of cases of anxiety and depression during the pandemic period. For instance, a WHO report published in March 2022 stated that in the ... Read More
-
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report and Forecast 2023-2031
... by the prevalence of ADHD. The market attained at value of USD 20.2 billion in 2022. It is further expected to grow at a CAGR of 5.5% during the forecast period of 2023-2031 to attain ... Read More
-
U.S. Psychedelic Mushroom Market Size, Share & Trends Analysis Report By Product (Psilocybe, Gymnopilus, Panaeolus), By Form (Dried, Processed), By Application (De-addiction, Recreational), And Segment Forecasts, 2023 - 2030
... Trends The U.S. psychedelic mushroom market size is expected to reach USD 4,321.0 million by 2030, grow at a CAGR of 11.3% from 2023 to 2030 according to a new report by Grand View Research, ... Read More
-
Global Behavioral Targeting Supply, Demand and Key Producers, 2023-2029
... (2023-2029). Behavioural targeting or behavioural advertising is a marketing technique that employs web user information to strengthen advertising campaigns. The method involves gathering data from various sources about the potential customer’s online browsing and shopping ... Read More
-
Global Behavioral Targeting Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Behavioural ... Read More
-
Magnetoencephalography Market - By Product (Cryogenic/Conventional Systems, OPM Systems), By Application (Clinical, {Epilepsy, Autism, Dementia, Stroke, Traumatic brain injury}, Research), By End-use (Hospitals, Imaging Centers, Academic and Research Institutes) & Forecast, 2023 - 2032
... Market is anticipated to demonstrate growth during 2023–2032 owing to the constant technological innovations across magnetoencephalography that have improved the diagnosis of several neurological disorders, offered better clinical results, and increased the life expectancy among ... Read More
-
Vagus Nerve Stimulation Market By Product (Implantable VNS devices, External VNS devices), By Application (Epilepsy, Depression, Others), By End user (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... stimulation market size was valued at $488.5 million in 2022, and is projected to reach $836.1 million by 2032, growing at a CAGR of 5.5% from 2023 to 2032. Vagus nerve stimulation (VNS) is a ... Read More
-
Treatment-resistant Depression - Epidemiology Forecast - 2032
... Treatment Resistant Depression (TRD) epidemiology trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. Treatment Resistant Depression (TRD) Understanding Treatment Resistant Depression (TRD) Overview Treatment-resistant Depression (TRD) typically refers ... Read More
-
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... of OCD in 2023 in the 16 major markets. The marketed drugs space for OCD is made up of small molecules. Their modes of action are mainly gamma-aminobutyric acid type A receptor subunit agonists and ... Read More
-
Global Depression-MDD Drugs Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Depression-MDD Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Neurofeedback Market, by Product (Amplifiers, Electrodes or Sensors, and Computer Software), by System (Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), ... Read More
-
Global Benzodiazepines Market Growth (Status and Outlook) 2023-2029
... region and market sector of projected Benzodiazepines sales for 2023 through 2029. With Benzodiazepines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ... Read More
-
Legal Marijuana Market Analysis and forecast to 2032: By Product Type (Flower, Oil and Tinctures), By Species (Cannabis Indica, Cannabis Sativa, Cannabis Hybrid), By Strain (THC-dominant, CBD-dominant, Balanced THC and CBD), By Application (Medical, Adult Use), By Region (North America, Europe, Asia Pacific, Latin America, Africa)
... Use), By Region (North America, Europe, Asia Pacific, Latin America, Africa) Since the early 1900s, marijuana has been regulated as a drug in the United States, with laws prohibiting its use, sale, and cultivation. In ... Read More
-
Health Coaching Market By Type (Holistic and Wellness Health Coaching, Primal/Paleo Health Coaching), By Mode (Online, Offline), By Duration (Less Than 6 Months, 6 Months To 12 Months), By Application (General Wellness, Behavioral Health Disorders, Chronic Diseases): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Chronic Diseases): Global Opportunity Analysis and Industry Forecast, 2021-2031 The Health Coaching Market was valued for $16,914.65 million in 2021 and is estimated to reach $34,812.48 million by 2031, exhibiting a CAGR of 7.4% from ... Read More
-
Global Escitalopram Oxalate API Market Report, History and Forecast 2018-2029
... 2022, is projected to reach a revised size of US$ 103.36 million by 2029, growing at a CAGR of 6.93% during the forecast period 2023-2029. North American market for Escitalopram Oxalate API was valued at ... Read More
-
Family Counseling & Crisis Intervention Services in the US - Industry Market Research Report
... for alcoholism and drug addiction, rehabilitation services, shelter and food services, marriage and parenting counseling, crisis centers and self-help organizations. The recipients come from all age groups. The need for these services is countercyclical, meaning ... Read More
-
Behavioral Therapists in the US - Industry Market Research Report
... the Substance Abuse and Mental Health Administration, one in four adults suffers from a mental health condition. In recent years, destigmatizing mental health has encouraged more of these patients to find a behavioral therapist. Other ... Read More
-
Global Venlafaxine API Market Growth 2023-2029
... region and market sector of projected Venlafaxine API sales for 2023 through 2029. With Venlafaxine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
Research Assistance
